mariateresa rossi

University of Brescia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (8)

Anna Belloni Fortina

University of Padua

ITALY

View details

MARINA VENTURINI

Assistant Professor

University of Brescia

ITALY

View details

simone ribero

University of Turin

ITALY

View details

Andrea Carugno

Adjunct Professor

University of Milano-Bicocca

ITALY

View details

Paolo AMERIO

Full professor

ITALY

View details

Luca Bettolini

ITALY

View details

Maddalena Napolitano

University of Naples Federico II

ITALY

View details

Maria Concetta Fargnoli

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

mariateresa rossi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study

Effectiveness of Tralokinumab Across Atopic Dermatitis Phenotypes

Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review

A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis

Drug Survival of Upadacitinib and Predicting Factors of Discontinuation in Adult Patients Affected by Moderate-to-Severe Atopic Dermatitis: An Italian Multicenter Analysis

AtopyReg<SUP>®</SUP>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History

Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study

“Your Skin Tells You” Campaign for Keratinocyte Cancers: When Individuals’ Selection Makes the Difference

Definition of the Clinical Characteristics of Patients with Moderate and Severe Atopic Dermatitis for Whom Narrow-Band UVB (NB-UVB) and Medium-Dose UVA1 Phototherapies Are Still Valuable Treatment Options at the Age of Biologics

A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis

Collaborators (8)

Anna Belloni Fortina

MARINA VENTURINI

simone ribero

Andrea Carugno

Paolo AMERIO

Luca Bettolini

Maddalena Napolitano

Maria Concetta Fargnoli

Make your next move.